BR0111541A - Formulações lipossÈmicas inibidoras de timidilato sintase de benzoquinazolina - Google Patents

Formulações lipossÈmicas inibidoras de timidilato sintase de benzoquinazolina

Info

Publication number
BR0111541A
BR0111541A BR0111541-3A BR0111541A BR0111541A BR 0111541 A BR0111541 A BR 0111541A BR 0111541 A BR0111541 A BR 0111541A BR 0111541 A BR0111541 A BR 0111541A
Authority
BR
Brazil
Prior art keywords
thymidylate synthase
benzoquinazoline
liposomal formulations
inhibiting
formulations
Prior art date
Application number
BR0111541-3A
Other languages
English (en)
Original Assignee
Osi Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osi Pharm Inc filed Critical Osi Pharm Inc
Publication of BR0111541A publication Critical patent/BR0111541A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"FORMULAçõES LIPOSSÈMICAS INIBIDORAS DE TIMIDILATO SINTASE DE BENZOQUINAZOLINA". Formulações de inibidor de timidilato sintase de benzoquinazolina encapsulado com lipossoma são fornecidas. Os lipossomas têm farmacocinéticos melhorados e eficácia intensificada como agentes antitumorais comparados à droga livre. As formulações incluem lipossomas compreendendo pelo menos uma fosfatidilcolina, um colesterol e um inibidor de timidilato sintase de benzoquinazolina.
BR0111541-3A 2000-06-09 2001-06-06 Formulações lipossÈmicas inibidoras de timidilato sintase de benzoquinazolina BR0111541A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21059200P 2000-06-09 2000-06-09
PCT/US2001/018224 WO2001095884A2 (en) 2000-06-09 2001-06-06 Liposomal benzoquinazoline thymidylate synthase inhibitor formulations

Publications (1)

Publication Number Publication Date
BR0111541A true BR0111541A (pt) 2003-07-01

Family

ID=22783495

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111541-3A BR0111541A (pt) 2000-06-09 2001-06-06 Formulações lipossÈmicas inibidoras de timidilato sintase de benzoquinazolina

Country Status (15)

Country Link
US (2) US6689381B2 (pt)
EP (1) EP1286661A2 (pt)
JP (1) JP2004503491A (pt)
KR (1) KR100851957B1 (pt)
CN (1) CN1446080A (pt)
AU (2) AU7526901A (pt)
BR (1) BR0111541A (pt)
CA (1) CA2412165A1 (pt)
IL (2) IL153230A0 (pt)
MX (1) MXPA02012068A (pt)
NZ (1) NZ522842A (pt)
PL (1) PL360470A1 (pt)
TW (1) TWI282741B (pt)
WO (1) WO2001095884A2 (pt)
ZA (1) ZA200209524B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004047802A2 (en) * 2002-11-26 2004-06-10 Gilead Sciences, Inc. Liposomal formulations
US20090060998A1 (en) * 2004-01-14 2009-03-05 Gilead Sciences, Inc. Lipid-based dispersions useful for drug delivery
WO2006012502A2 (en) * 2004-07-23 2006-02-02 Rigel Pharmaceuticals, Inc. Formulation of insoluble small molecule therapeutics in lipid-based carriers
WO2006014035A1 (en) * 2004-08-06 2006-02-09 Biospectrum, Inc. Multiple layered liposome and preparation method thereof
AU2005284909B2 (en) * 2004-09-13 2011-11-17 Gilead Sciences, Inc. Delivering iron to an animal
WO2006078253A1 (en) * 2005-01-20 2006-07-27 Osi Pharmaceuticals, Inc. Method of reclaiming drug compound osi-7904 from liposomal drug manufacturing stream
US20060159735A1 (en) * 2005-01-20 2006-07-20 Nicholas Bonham Method of reclaiming drug compound from liposomal drug manufacturing stream
EP1745788A1 (de) * 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
CN100348194C (zh) * 2005-07-26 2007-11-14 康辰医药发展有限公司 盐酸洛拉曲克的脂质体制剂及其制备方法
CA2631875A1 (en) * 2005-12-06 2007-10-04 Rigel Pharmaceuticals, Inc. Formulation of insoluble small molecule therapeutics in lipid-based carriers
US9493810B2 (en) * 2012-06-07 2016-11-15 Pioma, Inc. 5-ALA for detection of brain tumors
JP2015524410A (ja) * 2012-07-18 2015-08-24 オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． エポキシケトン系プロテアソーム阻害剤のリポソーム組成物
MX2019001756A (es) 2016-08-12 2019-05-09 L E A F Holdings Group Llc Antifolatos poliglutamados alfa y gamma-d y sus usos.
US11779584B2 (en) 2018-02-07 2023-10-10 L.E.A.F. Holdings Group Llc Alpha polyglutamated pemetrexed and uses thereof
WO2019157129A1 (en) 2018-02-07 2019-08-15 L.E.A.F. Holdings Group Llc Alpha polyglutamated pralatrexate and uses thereof
EP3752157A4 (en) 2018-02-14 2022-07-06 L.E.A.F Holdings Group LLC GAMMA-POLYGLUTAMATED LOMETREXOLE AND USES THEREOF

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460577A (en) * 1977-09-30 1984-07-17 Farmitalia Carlo Erba S.P.A. Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4755388A (en) * 1984-11-09 1988-07-05 The Regents Of The University Of California Liposome-encapsulated 5-fluoropyrimidines and methods for their use
US4753788A (en) * 1985-01-31 1988-06-28 Vestar Research Inc. Method for preparing small vesicles using microemulsification
GB9013615D0 (en) 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
EP0671953A4 (en) 1992-11-13 1996-01-10 Univ Ohio State Res Found ANALOGS OF N- (4-HYDROXYPHENYL) RETINAMIDE-O-GLUCURONIDE ARYLAMIDE.
JPH11199488A (ja) * 1998-01-09 1999-07-27 Sankyo Co Ltd 抗腫瘍薬のリポソーム化製剤

Also Published As

Publication number Publication date
JP2004503491A (ja) 2004-02-05
KR20030038552A (ko) 2003-05-16
AU2001275269B2 (en) 2006-07-13
US20040057990A1 (en) 2004-03-25
MXPA02012068A (es) 2004-08-19
US6689381B2 (en) 2004-02-10
ZA200209524B (en) 2003-11-22
CN1446080A (zh) 2003-10-01
PL360470A1 (en) 2004-09-06
EP1286661A2 (en) 2003-03-05
CA2412165A1 (en) 2001-12-20
KR100851957B1 (ko) 2008-08-12
WO2001095884A2 (en) 2001-12-20
AU7526901A (en) 2001-12-24
NZ522842A (en) 2004-11-26
US20020034538A1 (en) 2002-03-21
TWI282741B (en) 2007-06-21
IL153230A (en) 2009-02-11
IL153230A0 (en) 2003-07-06
WO2001095884A3 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
BR0111541A (pt) Formulações lipossÈmicas inibidoras de timidilato sintase de benzoquinazolina
WO2002000194A3 (en) Polymeric micelle compositions
AU2002232788A1 (en) Self forming, thermodynamically stable liposomes and their applications
WO2004047802A3 (en) Liposomal formulations
ATE423547T1 (de) N-acyl-phosphatidylethanolamin-vermittelte wirkstoffdarreichung in liposomenform
DE60036861D1 (de) Verkapselung biologisch aktiver komplexe in liposomen
DE60237162D1 (de) Liposomenladung mit metallionen
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
WO2002072011A3 (en) Stabilized therapeutic and imaging agents
MXPA03002568A (es) Derivados de sulfonamida farmaceuticamente activos que incluyen fracciones lipofilicas e ionizables como inhibidores de proteinas junquinasas.
IL155291A0 (en) Liposomal formulation of mitoxantrone
BR9812316A (pt) Formulações de camptotecina lipossÈmica
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
WO2000003753A3 (en) Microdisperse drug delivery systems
DK1733725T4 (da) Farmaceutiske formuleringer omfattende mindst én HIV-proteaseinhiberende forbindelse
AU2001234089A1 (en) Cancer remedy comprising anthranilic acid derivative as active ingredient
AU3408901A (en) Cancer remedy comprising anthranilic acid derivative as active ingredient
MXPA03000471A (es) Transportador de grabacion para almacenar un trabajo digital.
ATE419833T1 (de) Modulares zielgerichtetes liposomales verabreichungssytem
TR200102778T2 (tr) Lipozom preparatları
WO2004037223A3 (de) Liposomen formende zusammensetzung
IT1317049B1 (it) Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv.
DE60117465D1 (de) Lipide mit aminoxygruppe
AU2002214868A1 (en) Therapeutic oligonucleotides of reduced toxicity
AU2001258106A1 (en) Lipid carrier compositions for improved drug retention

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10(VIII), 13 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.